Myeloproliferative Neoplasms

Top Story

Myeloproliferative neoplasms significantly increase thrombotic risk

January 15, 2018

Stem cell transplantation specialist joins Fred Hutchinson Cancer Research Center

January 11, 2018
Professor Geoffrey Hill has been appointed director of hematopoietic stem cell transplantation at Fred Hutchinson Cancer Research Center. His appointment will take…

HemOnc Today honors inaugural Next Gen Innovators

HemOnc Today, January 10, 2018
HemOnc Today honored its inaugural class of Next Gen Innovators during the ASH Annual Meeting and Exposition. The Next Gen Innovators are a highly select group of early…
In the Journals PlusPerspective

Ruxolitinib fails to improve outcomes for high-risk essential thrombocythemia

January 5, 2018
Ruxolitinib did not demonstrate superiority over best available second-line therapy among patients with
More Headlines »

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Meeting News Coverage

VIDEO: New approaches demonstrate potential to exploit immune system to treat cancer

April 30, 2016
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium


Ace the Case: 61-Year-Old Male Who Presents to the ER with Worsening Back Pain

There is no commercial support for this activity.

This “Ace the Case” activity will review the diagnosis and management of patients with high-risk multiple…
More »